Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas

Oncogene volume 23, pages 4646–4654 (2004)Cite this article

Abstract

Gastric carcinogenesis involves multiple genetic and epigenetic alterations. Epigenetic silencing of tumor-related genes due to CpG island methylation (CIM) has been recently reported in gastric cancer, but the role in precursor lesions is not well understood. We analysed the methylation status of the tumor suppressor gene p16, the DNA mismatch repair gene hMLH1, and four CpG islands (MINT1, MINT2, MINT25, and MINT31) using methylation-specific polymerase chain reaction in 35 polypoid adenomas and 46 flat dysplasias unassociated with carcinoma, 34 early adenocarcinomas (T1N0M0) and associated adenomas/dysplasias, and corresponding adjacent non-neoplastic mucosa. The extent of CIM was defined by the fraction of methylated loci (methylation index), and compared with previously characterized genetic alterations (microsatellite instability (MSI) and APC gene mutation). We found that methylation of p16 was more frequent in adenocarcinoma-associated dysplasias/adenomas (29%) and adenocarcinomas (44%) as compared to flat dysplasias (4%) and adenomas (18%) unassociated with adenocarcinoma (P=0.001). The mean methylation index increased from normal/chronic gastritis (CG) mucosa (0.09) to intestinal metaplasia (IM) (0.16), flat dysplasias (0.40) or polypoid adenomas (0.41) unassociated with carcinoma, dysplasias/adenomas associated with carcinoma (0.44), and adenocarcinomas (0.44). There was no difference in frequencies of high-level CpG island methylation (CIM-H, methylation index ⩾0.5) among flat dysplasias (50%) and polypoid adenomas (51%) unassociated with carcinoma, dysplasias/adenomas associated with adenocarcinoma (47%), and adenocarcinoma (47%). CIM-H was present in 15% of IM, but not in normal/CG mucosa. There was a significant correlation between methylation of hMLH1 and high-level of microsatellite instability (MSI-H): methylation of hMLH1 was present in 71% of MSI-H tumors, but only 8% of MSI-low tumors and 13% of microsatellite-stable tumors (P=0.0001). There was no statistical difference between methylation index and APC mutation. Our results indicate that concurrent promoter methylation is an early and frequent event in gastric tumorigenesis, including both MSI-H and microsatellite-stable neoplasms. Methylation of the p16 gene may contribute to the malignant transformation of gastric precursor lesions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Akiyama Y, Nakasaki H, Nihei Z, Iwama T, Nomizu T, Utsunomiya J and Yuasa Y . (1996). Jpn. J. Cancer Res., 87, 595–601.

  • Bankfalvi A, Navabi H, Bier B, Bocker W, Jasani B and Schmid KW . (1994). J. Pathol., 174, 223–228.

  • Baylin SB and Herman JG . (2000). Trends Genet., 16, 168–174.

  • Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H . (1994). Cancer Res., 54, 3845–3852.

  • Correa P . (1992). Cancer Res., 52, 6735–6740.

  • Correa P and Shiao YH . (1994). Cancer Res., 54, 1941s–1943s.

  • Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW and Skinner KA . (2000). Cancer Res., 60, 5021–5026.

  • Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA and Laird PW . (2001). Cancer Res., 61, 3410–4318.

  • Endoh Y, Tamura G, Ajioka Y, Watanabe H and Motoyama T . (2000). Am. J. Pathol., 157, 717–722.

  • Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG and Meltzer SJ . (2001). Oncogene, 20, 329–335.

  • Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG and Meltzer SJ . (1999). Cancer Res., 59, 1090–1095.

  • Fujimoto J, Yasui W, Tahara H, Tahara E, Kudo Y, Yokozaki H and Tahara E . (2000). Cancer Lett., 149, 125–134.

  • Gunther T, Schneider-Stock R, Pross M, Manger T, Malfertheiner P, Lippert H and Roessner A . (1998). Pathol. Res. Pract., 194, 809–813.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K and Yuasa Y . (2002). Int. J. Cancer, 87, 654–658.

  • Jang TJ, Kim DI, Shin YM, Chang HK and Yang CH . (2001). Int. J. Cancer, 93, 629–634.

  • Jones PA and Laird PW . (1999). Nat. Genet., 21, 163–167.

  • Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y and Tsuchiya M . (1982). Cancer, 50, 2496–2503.

  • Kanai Y, Ushijima S, Ochiai A, Eguchi K, Hui A and Hirohashi S . (1998). Cancer Lett., 122, 135–141.

  • Kang YH, Lee HS and Kim WH . (2002). Lab. Invest., 82, 285–291.

  • Kang GH, Lee S, Kim JS and Jung HY . (2003). Lab. Invest., 83, 519–526.

  • Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG . (2001). Cancer Res., 61, 2847–2851.

  • Kihana T, Tsuda H, Hirota T, Shimosato Y, Sakamoto H, Terada M and Hirohashi S . (1991). Jap. J. Cancer Res., 82, 308–314.

  • Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T and Tsuneyoshi M . (1994). Cancer, 74, 2896–2907.

  • Kwong J, Lo KW, To KF, Teo PM, Johnson PJ and Huang DP . (2002). Clin. Cancer Res., 8, 131–137.

  • Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Rashid A, Hamilton SR and Wu TT . (2002a). Am. J. Pathol., 161, 611–618.

  • Lee S, Kim WH, Jung HY, Yang MH and Kang GH . (2002b). Am. J. Pathol., 161, 1015–1022.

  • Leung WK, Yu J, Ng EK, To KF, Ma PK, Lee TL, Go MY, Chung SC and Sung JJ . (2001). Cancer, 91, 2294–2301.

  • Li E, Beard C and Jaenisch R . (1993). Nature, 366, 362–365.

  • Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M and Satodate R . (1995). J. Pathol., 176, 249–258.

  • Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B and Gazdar AF . (2001). Cancer Res., 61, 8659–8663.

  • Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zochbauer-Muller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP and Gazdar AF . (2002). Clin. Cancer Res., 8, 514–519.

  • Momparler RL and Bovenzi V . (2000). J. Cell Physiol., 183, 145–154.

  • Moskaluk CA and Kern SE . (1997). Am. J. Pathol., 150, 1547–1552.

  • Nakatsuru S, Yanagisawa A, Furukawa Y, Ichii S, Kato Y, Nakamura Y and Horii A . (1993). Hum. Mol. Genet., 2, 1463–1465.

  • Orlowska J, Jarosz D, Pachlewski J and Butruk E . (1995). Am. J. Gastroenterol., 90, 2152–2159.

  • Panning B and Jaenisch R . (1998). Cell, 93, 305–308.

  • Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ and Lee JY . (1999). Cancer Res., 59, 4257–4260.

  • Rhyu MG, Park WS, Jung YJ, Choi SW and Meltzer SJ . (1994). Gastroenterology, 106, 1584–1588.

  • Stadtlander CT and Waterbor JW . (1999). Carcinogenesis, 20, 2195–2208.

  • Tamura G, Maesawa C, Suzuki Y, Tamada H, Satoh M, Ogasawara S, Kashiwaba M and Satodate R . (1994). Cancer Res., 54, 1149–1151.

  • Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP . (1999a). Proc. Natl. Acad. Sci. USA, 96, 8681–8686.

  • Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB and Issa JP . (1999b). Cancer Res., 59, 5438–5442.

  • Toyota M and Issa JP . (2000). Electrophoresis, 21, 329–333.

  • Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, Wilson KT, James SP, Yin J, Fleisher AS, Zou T, Silverberg SG, Kong D and Meltzer SJ . (2000). Oncogene, 19, 3642–3646.

  • Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M . (2001). Cancer Res., 61, 8540–8546.

  • Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M and Gazdar AF . (2001). Clin. Cancer Res., 7, 584–589.

  • Wajed SA, Laird PW and DeMeester TR . (2001). Ann. Surg., 234, 10–20.

  • Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S and Motoyama T . (2002). Am. J. Pathol., 161, 399–403.

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, MD Anderson Cancer Center, Houston, 77030, TX, USA

    Jae-Hyuk Lee, Seun-Ja Park, Asif Rashid, Stanley R Hamilton & Tsung-Teh Wu

  2. Mayo Clinic, Rochester, 55905, MI, USA

    Susan C Abraham

  3. Chonnam National University Medical School, Kwangju, 501-190, South Korea

    Jae-Sung Seo, Jong-Hee Nam, Chan Choi & Sang-Woo Juhng

Authors
  1. Jae-Hyuk Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seun-Ja Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan C Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jae-Sung Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jong-Hee Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chan Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sang-Woo Juhng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Asif Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stanley R Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tsung-Teh Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsung-Teh Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JH., Park, SJ., Abraham, S. et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23, 4646–4654 (2004). https://doi.org/10.1038/sj.onc.1207588

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207588

Keywords

This article is cited by

Search

Advanced search

Quick links